Atlas Trials

Encephalitis, Tick-Borne

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Encephalitis, Tick-Borne

RecordFirmDate
Fever After Tick Bite Study (NCT03932448)Göteborg University2019-05-15
Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401) (NCT00894686)Pfizer2009-04-26
Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children (NCT00840801)Pfizer2009-02-06
TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223) (NCT00503529)Pfizer2007-07-01
Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years (NCT00452621)Novartis2007-02-01
Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule (NCT00460486)Pfizer2006-09-01
Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults (NCT00311493)Novartis2006-02-01
Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children (NCT00163618)Pfizer2005-06-01
TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209) (NCT00161967)Pfizer2005-05-01
Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225) (NCT00163540)Pfizer2005-05-01
Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children (NCT00311441)Novartis2005-03-01
Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years (NCT00161954)Pfizer2004-03-01
FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years (NCT00161876)Pfizer2002-05-01
FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years (NCT00161850)Pfizer2002-02-01
FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years (NCT00161889)Pfizer2002-02-01
Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR (NCT00161824)Pfizer2001-10-01

Track Encephalitis, Tick-Borne automatically

Every clearance here is in the API, with alerts when new ones post.